ASH Comments for the Cell and Gene Therapy Access Model for Sickle Cell Disease
Nov 03
2023
ÎÚÑ»´«Ã½. (2023).
ASH Comments for the Cell and Gene Therapy Access Model for Sickle Cell Disease.
Retrieved from /advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-comments-for-the-cell-and-gene-therapy-access-model-for-sickle-cell-disease.
ÎÚÑ»´«Ã½.
"ASH Comments for the Cell and Gene Therapy Access Model for Sickle Cell Disease." Hematology.org.
/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-comments-for-the-cell-and-gene-therapy-access-model-for-sickle-cell-disease
(label-accessed February 05, 2025).
"ÎÚÑ»´«Ã½."
ASH Comments for the Cell and Gene Therapy Access Model for Sickle Cell Disease, 05 Feb. 2025 ,
/advocacy/policy-news-statements-testimony-and-correspondence/testimony-and-correspondence/ash-comments-for-the-cell-and-gene-therapy-access-model-for-sickle-cell-disease.
